Status:
COMPLETED
Impact of Bariatric Surgery in Patients With Morbid Obesity
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Obesity, Morbid
Anal Incontinence
Eligibility:
All Genders
18-65 years
Brief Summary
The main objective is to compare the prevalence of anal incontinence (AI) before and after bariatric surgery in obese patients. Inclusion: Patients who are scheduled for a bariatric surgical procedur...
Detailed Description
This study is proposed to all obese patients evaluated for potential bariatric surgery during a multidisciplinary evaluation for about 1 year following current french national recommendations. Demogr...
Eligibility Criteria
Inclusion
- BMI\>40 kg/m2
- BMI\> 35 kg/m2 with comorbidity ( high blood pressure, diabetes, dyslipidemia, sleep apnea syndrome)
Exclusion
- anal incontinence due to chronic diarrhea
- transit constipation
- peripheral neuropathy (diabetes ...)
- patient opposition
- any previous bariatric surgical procedure
- any pelvic surgical procedure performed during the study period (between preoperative and postoperative period at 6 months)
Key Trial Info
Start Date :
January 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04009356
Start Date
January 22 2020
End Date
January 1 2022
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy - Département Chirurgie Viscérale, Métabolique et Cancérologique CVMC (7ème étage)
Nancy, France, 54511